Impact of consensus molecular subtyping (CMS) on overall survival (OS) and progression free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Southern California, USC Norris Comprehensive Cancer Center, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), University of California, San Francisco, Yale Cancer Center, Duke Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Oregon Health & Science University, Genentech, University of North Carolina at Chapel Hill
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2765339798
